More than a successful symposium, 3D Modeling Life 2026 sent a clear signal: the biomedical ecosystem is actively seeking more predictive, human-relevant models and more strategic dialogue on how to translate them into research and innovation practice. Held on 18–19 February 2026 at Sapienza University of Rome , Modeling Life 2026 – 3D Human-Based Technologies in Modern Biology brought together academic, industrial, and public-sector stakeholders around one central question

Terrassa (Barcelona), 25 February 2026 — FRESCI by SCIENCE&STRATEGY SL today announced the launch of VISI-ON-BRAIN (Cutting-edge Human In Vitro and In Silico Biomedical Tools on Brain Disorders), a Horizon Europe project funded with over €4.5 million under the Marie Skłodowska-Curie Actions – Doctoral Networks (MSCA-DN). Over 48 months (2026–2029) , the consortium will train 15 doctoral researchers to develop and apply next-generation human in vitro and in silico approaches

Transforming scientific discovery into real-world health impact is no longer just a scientific challenge. It is a strategic exercise that demands alignment between evidence, regulation, and innovation pathways. In today’s rapidly evolving scientific landscape, the ability to translate a discovery into a real-world health solution is no longer a purely scientific challenge. It is a strategic one. This is where innovative frameworks and tools come into play, enabling researcher

**Advanced Therapy (ATMP) projects often fail from poor decision-making, not weak science. FRESCI tackles this bottleneck by structuring uncertainty, aligning evidence with strategic goals, and applying proactive regulatory science. Our focus: smarter decisions and clear thinking to navigate ATMP complexity and translate scientific potential into approved, accessible therapies.